4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065253
10% owner acquired 8,606,249 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flagship Ventures Fund V, L.P. 10% owner | 2017-12-12 | Conversion | +8,606,249 | 8,918,749 | D | ||
| Derivatives | |||||||
| Flagship Ventures Fund V, L.P. 10% owner | 2017-12-12 | Conversion · Series A-1 Preferred Stock | −8,324,999 | 0 | D | ||
| Flagship Ventures Fund V, L.P. 10% owner | 2017-12-12 | Conversion · Series A-2 Preferred Stock | −125,000 | 0 | D | ||
| Flagship Ventures Fund V, L.P. 10% owner | 2017-12-12 | Conversion · Series B-1 Preferred Stock | −156,250 | 0 | D | ||
Loading xslF345X03/doc4.xml…